Analyst Ratings For NASDAQ:CCXI – ChemoCentryx (NASDAQ:CCXI)
Today, Canaccord Genuity initiated coverage on NASDAQ:CCXI – ChemoCentryx (NASDAQ:CCXI) with a Buy with a price target of $17.00.
Some recent analyst ratings include
- 5/16/2018-Canaccord Genuity initiated coverage with a Buy rating.
- 5/10/2018-Cowen Reiterated Rating of Hold.
- 5/2/2018-HC Wainwright initiated coverage with a Buy ➝ Buy rating.
- 3/13/2018-JPMorgan Chase Reiterated Rating of Overweight ➝ Overweight.
- 2/21/2017-JMP Securities initiated coverage with a Mkt Outperform ➝ Outperform rating.
Recent Insider Trading Activity For NASDAQ:CCXI – ChemoCentryx (NASDAQ:CCXI)
NASDAQ:CCXI – ChemoCentryx (NASDAQ:CCXI) has insider ownership of 14.50% and institutional ownership of 47.58%.
- On 5/8/2018 Susan M Kanaya, CFO, sold 65,328 with an average share price of $11.53 per share and the total transaction amounting to $753,231.84.
- On 5/2/2018 Markus J Cappel, Insider, sold 50,000 with an average share price of $11.02 per share and the total transaction amounting to $551,000.00.
- On 5/2/2018 Susan M Kanaya, CFO, sold 1,366 with an average share price of $11.50 per share and the total transaction amounting to $15,709.00.
- On 5/1/2018 Thomas J Schall, CEO, sold 17,127 with an average share price of $11.00 per share and the total transaction amounting to $188,397.00.
- On 8/1/2017 Roger C Lucas, Director, sold 2,250 with an average share price of $10.07 per share and the total transaction amounting to $22,657.50.
- On 7/13/2017 Petrus Bekker, Insider, sold 76,013 with an average share price of $9.95 per share and the total transaction amounting to $756,329.35.
- On 7/12/2017 Petrus Bekker, Insider, sold 30,000 with an average share price of $9.98 per share and the total transaction amounting to $299,400.00.
Recent Trading Activity for NASDAQ:CCXI – ChemoCentryx (NASDAQ:CCXI)
Shares of NASDAQ:CCXI – ChemoCentryx closed the previous trading session at 11.88 up +0.45 3.94% with 11.899999618530273 shares trading hands.